Get the Stockscreener App
21.86
2.58%
0.55
After Hours:
21.86
Azenta Inc stock is traded at $21.86, with a volume of 1.15M.
It is up +2.58% in the last 24 hours and down -21.59% over the past month.
Azenta Inc provides biological and chemical sample exploration and management solutions, using precision automation and cryogenics to develop automated ultra-cold storage. It serves customers from research to commercialization with sample management, automated storage, genomic services, consumables, informatics, and repository services. The company operates through two segments: Sample Management Solutions, offering SRS and Core Products such as automated stores, cryogenic systems, sample tubes, consumables, instruments, and thawing devices, which generate majority of its revenue; and Multiomics, which provides genomic analysis services. The company operates in United States, China, United Kingdom, rest of Europe, and others, with majority of its revenue in the United States.
See More
Previous Close:
$21.31
Open:
$21.91
24h Volume:
1.15M
Relative Volume:
1.38
Market Cap:
$1.01B
Revenue:
$595.19M
Net Income/Loss:
$28.96M
P/E Ratio:
-17.24
EPS:
-1.2679
Net Cash Flow:
$30.93M
1W Performance:
+1.34%
1M Performance:
-21.59%
6M Performance:
-23.97%
1Y Performance:
-41.16%
1-Day Range:
$21.17
$22.19
1-Week Range:
$19.93
$22.19
52-Week Range:
$19.93
$41.73
Azenta Inc Stock (AZTA) Company Profile
Name
Azenta Inc
Sector
Industry
Phone
(978) 262-2400
Address
200 SUMMIT DRIVE, BURLINGTON
Compare AZTA vs ISRG, BDX, ALC, MDLN, RMD
| Stocks | Price | Market Cap | Revenue | Net Income | Cash Flow | EPS |
|---|---|---|---|---|---|---|
AZTA
Azenta Inc
|
21.86 | 981.57M | 595.19M | 28.96M | 30.93M | -1.2679 |
ISRG
Intuitive Surgical Inc
|
469.98 | 167.61B | 10.06B | 2.88B | 2.49B | 7.876 |
BDX
Becton Dickinson Co
|
158.27 | 44.35B | 21.92B | 1.76B | 2.63B | 6.1223 |
ALC
Alcon Inc
|
75.26 | 36.19B | 10.40B | 980.00M | 1.61B | 1.9749 |
MDLN
Medline Inc
|
42.67 | 34.11B | 28.43B | 1.16B | 1.26B | 1.4457 |
RMD
Resmed Inc
|
226.31 | 33.24B | 5.40B | 1.49B | 1.78B | 10.12 |
Azenta Inc Stock (AZTA) Upgrades & Downgrades
| Date | Action | Analyst | Rating Change |
|---|---|---|---|
| Jan-05-26 | Upgrade | Evercore ISI | In-line → Outperform |
| Dec-19-25 | Reiterated | Needham | Buy |
| Oct-30-25 | Upgrade | Jefferies | Hold → Buy |
| Aug-06-25 | Upgrade | Raymond James | Mkt Perform → Outperform |
| Jul-22-25 | Resumed | Stephens | Equal-Weight |
| Dec-18-24 | Upgrade | Stephens | Equal-Weight → Overweight |
| Apr-04-24 | Initiated | Jefferies | Hold |
| Feb-01-24 | Reiterated | B. Riley Securities | Buy |
| Jul-19-23 | Initiated | Raymond James | Mkt Perform |
| May-10-23 | Downgrade | KeyBanc Capital Markets | Overweight → Sector Weight |
| Feb-09-23 | Downgrade | Stephens | Overweight → Equal-Weight |
| Jan-03-23 | Downgrade | Evercore ISI | Outperform → In-line |
| Mar-31-22 | Resumed | B. Riley Securities | Buy |
| Mar-21-22 | Initiated | Evercore ISI | Outperform |
View All
Azenta Inc Stock (AZTA) Latest News
Azenta: Life Science Player Fails To Come To Life (NASDAQ:AZTA) - Seeking Alpha
Congress Asset Management Co. Invests $42.76 Million in Azenta, Inc. $AZTA - MarketBeat
Contrasting Azenta (NASDAQ:AZTA) & Talkspace (NASDAQ:TALK) - Defense World
Trading Recap: Is Azenta Inc stock trending bullishForecast Cut & Free Reliable Trade Execution Plans - baoquankhu1.vn
Needham reiterates Azenta stock rating citing growth drivers By Investing.com - Investing.com Australia
Azenta's (AZTA) Buy Rating Reiterated at Needham & Company LLC - MarketBeat
Needham reiterates Azenta stock rating citing growth drivers - Investing.com
Needham Reiterates Buy Rating on Azenta (AZTA) with Price Target of $44 | AZTA Stock News - GuruFocus
Azenta (NASDAQ:AZTA) Hits New 1-Year LowHere's What Happened - MarketBeat
Azenta Details UK Biocentre Buyout to Expand Europe Biobanking, Near-Term EBITDA Dilution Seen - Yahoo Finance
Azenta stock hits 52-week low at $22.44 By Investing.com - Investing.com India
Azenta stock hits 52-week low at $22.44 - Investing.com
Azenta, Inc. (AZTA) Uk Biocentre LimitedM&A CallSlideshow (NASDAQ:AZTA) 2026-03-10 - Seeking Alpha
Azenta Announces Fiscal 2024 Second Quarter Earnings Conference Call and Webcast - GuruFocus
Aug Reactions: Can Azenta Inc sustain earnings growthMarket Volume Report & Smart Allocation Stock Tips - baoquankhu1.vn
Tenet Healthcare, Revvity, Avantor, Azenta, and Elanco Shares Plummet, What You Need To Know - Yahoo Finance
GW&K Investment Management LLC Has $32.47 Million Stake in Azenta, Inc. $AZTA - MarketBeat
Osborne Clarke advises shareholders of UK Biocentre on sale to Azenta Life Sciences - Osborne Clarke
Azenta Acquires UK Biocentre to Expand European Biorepository - The Globe and Mail
Azenta Details Turnaround at Raymond James Conference, Targets Margin Gains and Recurring Revenue Growth - MarketBeat
Investor Mood: Is Azenta Inc stock trending bullish2025 Support & Resistance & Fast Entry High Yield Stock Tips - baoquankhu1.vn
Fisher Asset Management LLC Sells 48,408 Shares of Azenta, Inc. $AZTA - MarketBeat
AZTA Technical Analysis & ETF Price Forecast - Intellectia AI
Azenta acquires UK Biocentre for £20.5 million By Investing.com - Investing.com Canada
Azenta acquires UK Biocentre for £20.5 million - Investing.com South Africa
Azenta completes strategic acquisition of UK Biocentre Limited, to expand biorepository capabilities - marketscreener.com
Azenta to Acquire UK Biocentre for GBP 20.5 Million to Build European SRS Hub - TradingView
Azenta (AZTA) acquires UK Biocentre in GBP 20.5m European hub deal - Stock Titan
Azenta Completes Strategic Acquisition of UK Biocentre Limited, to Expand Biorepository Capabilities - marketscreener.com
Vanguard Group Inc. Lowers Holdings in Azenta, Inc. $AZTA - MarketBeat
Azenta, Inc. (AZTA) Presents at 47th Annual Raymond James Institutional Investor ConferenceSlideshow - Seeking Alpha
Royce & Associates LP Has $9.88 Million Position in Azenta, Inc. $AZTA - MarketBeat
How The Azenta (AZTA) Story Is Shifting With Analyst Rethinks And New Buyback Plan - Yahoo Finance
Azenta, Inc. (NASDAQ:AZTA) Short Interest Update - MarketBeat
Azenta stock hits 52-week low at 23.88 USD By Investing.com - Investing.com Canada
Azenta at 47th Annual Raymond James Conference: Strategic Turnaround Insights - Investing.com Australia
Azenta (NASDAQ:AZTA) Hits New 12-Month LowHere's What Happened - MarketBeat
AZTA SEC FilingsAzenta Inc 10-K, 10-Q, 8-K Forms - Stock Titan
Azenta stock hits 52-week low at 23.88 USD - Investing.com South Africa
Azenta, Inc. (AZTA) Stock Analysis: Unveiling a 49.64% Potential Upside in the Healthcare Sector - DirectorsTalk Interviews
Azenta, Inc. (NASDAQ:AZTA) Given Average Rating of "Hold" by Brokerages - MarketBeat
AZTA Financials: Income Statement, Balance Sheet & Cash Flow - Stock Titan
Fulgent Genetics and Azenta Compared as Investments - National Today
Rate Hike: Can Azenta Inc keep up with sector leaders2025 Trading Volume Trends & Breakout Confirmation Alerts - baoquankhu1.vn
Azenta, Inc. (AZTA) Investor Outlook: Exploring a 37.95% Potential Upside in the Healthcare Sector - DirectorsTalk Interviews
Azenta Inc Stock (AZTA) Financials Data
Revenue
Net Income
Cash Flow
EPS
0.95%
0.04%
Open in Yahoo
|
Open in Google
|
Open in Finviz
|
Open in MarketWatch
|
Open in EDGAR
|
Open in Reuters
Cap:
|
Volume (24h):